PortfoliosLab logo
Alkermes plc (ALKS)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

IE00B56GVS15

CUSIP

00B56GVS1

IPO Date

Jul 16, 1991

Highlights

Market Cap

$4.59B

EPS (TTM)

$2.20

PE Ratio

12.65

PEG Ratio

-1,057.29

Total Revenue (TTM)

$1.21B

Gross Profit (TTM)

$1.02B

EBITDA (TTM)

$433.92M

Year Range

$22.90 - $36.45

Target Price

$39.71

Short %

10.87%

Short Ratio

6.79

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Alkermes plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


400.00%600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%NovemberDecember2025FebruaryMarchApril
406.18%
1,348.13%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Returns By Period

Alkermes plc had a return of -3.20% year-to-date (YTD) and 12.80% in the last 12 months. Over the past 10 years, Alkermes plc had an annualized return of -6.67%, while the S&P 500 had an annualized return of 10.27%, indicating that Alkermes plc did not perform as well as the benchmark.


ALKS

YTD

-3.20%

1M

-16.17%

6M

6.71%

1Y

12.80%

5Y*

11.62%

10Y*

-6.67%

^GSPC (Benchmark)

YTD

-6.06%

1M

-1.00%

6M

-4.87%

1Y

8.34%

5Y*

14.11%

10Y*

10.27%

*Annualized

Monthly Returns

The table below presents the monthly returns of ALKS, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20259.63%8.88%-3.82%-15.69%-3.20%
2024-2.49%9.76%-8.82%-9.35%-4.65%2.99%13.36%4.14%-1.62%-8.18%12.92%-0.90%3.68%
20239.61%-6.63%5.42%1.28%1.33%8.19%-6.45%-0.31%-4.04%-13.64%-0.21%14.91%6.16%
20229.63%-2.51%5.83%9.65%3.47%-0.20%-14.07%-7.54%-5.66%1.66%9.16%5.45%12.34%
20215.21%-9.29%-1.89%17.83%3.00%8.16%5.51%20.83%-1.34%-1.78%-27.63%6.11%16.59%
2020-14.66%19.70%-30.81%-4.92%19.33%18.64%-7.21%-8.16%0.18%-1.93%12.37%9.26%-2.21%
201911.39%1.22%9.68%-16.91%-28.96%4.64%2.75%-9.41%-7.01%0.10%7.63%-2.95%-30.87%
20184.46%-0.16%1.54%-23.62%6.62%-12.80%6.54%2.26%-5.35%-3.79%-10.75%-19.02%-46.08%
2017-2.64%4.42%3.54%-0.43%-0.84%0.36%-6.14%-6.67%0.12%-4.09%7.24%4.67%-1.53%
2016-59.67%0.81%5.95%16.26%16.75%-6.87%15.46%-12.28%7.45%7.19%12.74%-2.20%-29.98%
201523.38%-2.77%-13.21%-9.18%10.35%5.30%8.83%-14.94%-1.49%22.58%2.00%8.21%35.55%
201419.72%-0.02%-9.41%4.92%-0.97%9.87%-15.04%4.61%-4.16%17.91%8.84%6.43%44.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ALKS is 66, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of ALKS is 6666
Overall Rank
The Sharpe Ratio Rank of ALKS is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of ALKS is 6464
Sortino Ratio Rank
The Omega Ratio Rank of ALKS is 6161
Omega Ratio Rank
The Calmar Ratio Rank of ALKS is 6262
Calmar Ratio Rank
The Martin Ratio Rank of ALKS is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Alkermes plc (ALKS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for ALKS, currently valued at 0.45, compared to the broader market-2.00-1.000.001.002.003.00
ALKS: 0.45
^GSPC: 0.46
The chart of Sortino ratio for ALKS, currently valued at 0.90, compared to the broader market-6.00-4.00-2.000.002.004.00
ALKS: 0.90
^GSPC: 0.77
The chart of Omega ratio for ALKS, currently valued at 1.11, compared to the broader market0.501.001.502.00
ALKS: 1.11
^GSPC: 1.11
The chart of Calmar ratio for ALKS, currently valued at 0.19, compared to the broader market0.001.002.003.004.005.00
ALKS: 0.19
^GSPC: 0.47
The chart of Martin ratio for ALKS, currently valued at 2.06, compared to the broader market-5.000.005.0010.0015.0020.00
ALKS: 2.06
^GSPC: 1.94

The current Alkermes plc Sharpe ratio is 0.45. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Alkermes plc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.45
0.46
ALKS (Alkermes plc)
Benchmark (^GSPC)

Dividends

Dividend History


Alkermes plc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-71.61%
-10.07%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Alkermes plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alkermes plc was 96.15%, occurring on Jul 11, 2002. The portfolio has not yet recovered.

The current Alkermes plc drawdown is 71.61%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.15%Mar 2, 2000591Jul 11, 2002
-92.95%Jan 10, 1992755Jan 4, 1995537Feb 18, 19971292
-64.98%Feb 19, 199748Apr 28, 1997440Jan 26, 1999488
-44.58%Nov 4, 199118Nov 27, 199124Jan 3, 199242
-28.52%Mar 22, 199942May 19, 199957Aug 10, 199999

Volatility

Volatility Chart

The current Alkermes plc volatility is 11.96%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
11.96%
14.23%
ALKS (Alkermes plc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alkermes plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Alkermes plc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
ALKS: 12.7
The chart displays the Price-to-Earnings (P/E) ratio for ALKS, comparing it with other companies in the Biotechnology industry. Currently, ALKS has a P/E ratio of 12.7. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
2.04.06.08.010.0
ALKS: -1,057.3
The chart shows the Price/Earnings to Growth (PEG) ratio for ALKS compared to other companies in the Biotechnology industry. ALKS currently has a PEG ratio of -1,057.3. This PEG ratio is negative, which typically signals that the company's earnings are expected to decline. A negative PEG is not considered meaningful for valuation purposes.
PS Ratio
20.040.060.080.0100.0
ALKS: 2.9
This chart shows the Price-to-Sales (P/S) ratio for ALKS relative to other companies in the Biotechnology industry. Currently, ALKS has a P/S ratio of 2.9. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.010.0
ALKS: 3.1
The chart illustrates the Price-to-Book (P/B) ratio for ALKS in comparison with other companies in the Biotechnology industry. Currently, ALKS has a P/B value of 3.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items